We have recently updated our privacy policy to explain what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. You can disable cookies by changing the settings in your browser. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.


Outsourcing in Clinical Trials Canada

Wednesday 14th - Thursday 15th November 2012, Toronto, Canada

Arena International’s Outsourcing in Clinical Trials Canada conference aims to help sponsors improve and perfect their trial models by opening up lines of communication and sharing expertise on industry challenges. In-depth industry research with small to mid-size pharmaceutical and biotech companies allows us to formulate targeted presentations which address the greatest challenges of clinical outsourcing head-on, and give them the opportunity to utilize and incorporate relevant strategies into their trial processes.



OCT Canada

Outsourcing in Clinical Trials Canada featured in Pharma Technology Focus magazine!

Arena International is pleased to announce that Outsourcing in Clinical Trials Canada has been featured in it’s own supplement and distributed in the September 2012 issue of Pharma Technology Focus. Pharma Technology Focus is an online publication powered by http://www.pharmaceutical-technology.com/.

2nd Annual Outsourcing in Clinical Trials Canada

The aim of the conference is to collectively target all the challenges and issues faced by professionals in the industry to provide an array of solutions and methodologies that have been proven to overcome them.

Who should attend

Small-Mid level Biotech and Pharmaceutical professionals in Canada:

Argentina clinical research market tempts CROs, MNC pharma : GBI Research

The country is an attractive market for CROs due to its good clinical infrastructure, cost compliance, large population. A new report by GBI Research shows that MNC pharma companies and Contract Research Organizations (CROs) are making more investments in a new clinical research destination: Argentina.

Merck launches biosciences investment fund in Quebec

MONTREAL - A strong lifeline is being thrown to Quebec’s struggling biotech industry by U.S.-based drug giant Merck & Co. in partnership with Montreal venture fund manager Teralys Capital and other institutional investors.

Speakers Include:

Sonia Trepanier Picture

Sonia Trepanier

Director, Preclinical & Clinical Studies, Medicago

Owen Roberts Picture

Owen Roberts

Chief Financial Officer, Affinium Pharmaceutical

Andreas Orfanos Picture

Andreas Orfanos

Chief Medical Officer, Thrasos Innovation inc

Dr. Andreas Orfanos is the Chief Medical Officer, at Thrasos Innovation Inc. a bio-therapeutics company focused on the discovery and ...

Dex Bilkic Picture

Dex Bilkic

Leader, Business Support, Boehringer Ingelheim (Canada)Ltd